Civic AI
Procurement intelligence
Federal contract award
PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM, TASK ORDER TITLE: A NOVEL MULTI-ANTIGEN VACCINE (TNBCVAX) TO PREVENT TRIPLE NEGATIVE BREAST CANCER
UNIVERSITY OF OKLAHOMA · Department of Health and Human Services
- Value
- $1,107,542
- Start
- Sep 16, 2021
- End
- Nov 15, 2025
- Action date
- Apr 10, 2026
- PIID
- 75N91021F00003
- Status
- completed
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- OKLAHOMA CITY, OK
- Award type
- DELIVERY ORDER
Description
PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM, TASK ORDER TITLE: A NOVEL MULTI-ANTIGEN VACCINE (TNBCVAX) TO PREVENT TRIPLE NEGATIVE BREAST CANCER
Need modifications, related awards, and vendor peers? Open the full award workspace.